-
Mutational analysis of an oligoprogressive sarcomatoid hepatocellular carcinoma treated with an immune checkpoint inhibitor.
Study
EGAS00001005064
-
Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor-like Melanoma
Study
EGAS00001005065
-
Anal SCC cell line and parent tumour comparative whole exome sequencing
Study
EGAS00001005077
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit - 10x Genomics scRNAseq
Study
EGAS00001005098
-
Single-cell analysis of retinoblastoma heterogeneity
Study
EGAS00001005178
-
Sequencing of cancer autopsies and ctDNA
Study
EGAS00001005109
-
WES of clonally related neuroblastoma and teratoma
Study
EGAS00001005116
-
Paired exome and low-coverage genome sequencing of osteosarcoma
Study
EGAS00001005199
-
Engineering large chromosomal deletions by CRISPR-Cas9
Study
EGAS00001005134
-
Whole genome sequence and RNA-seq data from paired tumour and germline samples from mesothelioma patients.
Study
EGAS00001005196
-
The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival
Study
EGAS00001005201
-
mRNA capture sequencing and RT-qPCR for the detection of pathognomonic, novel and secondary fusion transcripts in formalin-fixed paraffin-embedded tissue: a sarcoma showcase
Study
EGAS00001005202
-
Dissecting the Spatial Heterogeneity of Single Circulating Tumor Cells in Hepatocellular Carcinoma
Study
EGAS00001005204
-
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
Study
EGAS00001005243
-
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Study
EGAS00001005222
-
Whole-genome landscape of adult T-cell leukemia/lymphoma
Study
EGAS00001005237
-
Targeted sequencing of follicular lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005238
-
Genomic characterization of retinoblastoma
Study
EGAS00001005248
-
Combining a Universal Telomerase Based Cancer Vaccine with Ipilimumab in Patients with Metastatic Melanoma - Five-year Follow up of a Phase I/IIa Trial
Study
EGAS00001005253
-
Whole genome sequencing of adult glioblastoma nuclei
Study
EGAS00001005256
-
Molecular characteristics in Burkitt lymphoma over age groups
Study
EGAS00001005270
-
ATAC-seq data in normal colon mucosa
Study
EGAS00001005281
-
Genomic Analysis of Focal Nodular Hyperplasia with Associated Hepatocellular Carcinoma Unveils its Malignant Potential
Study
EGAS00001005313
-
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
Study
EGAS00001005301
-
Pediatric tumor in a single child of three large nuclear families
Study
EGAS00001005321
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing - NGS targeted capture control cohort
Study
EGAS00001005325
-
Immune infiltrate and tumor microenvironment transcriptional programs stratify pediatric osteosarcoma into prognostic groups at diagnosis
Study
EGAS00001005326
-
The mutational landscape of primary central nervous system lymphoma (Hipo H050, A050, XD013)
Study
EGAS00001005339
-
WGS Leiomyosarcoma subtypes
Study
EGAS00001005341
-
Mongolia Western HCC
Study
EGAS00001005364
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005368
-
Single cell copy number and chromatin accessibility in primary multiple myeloma cells
Study
EGAS00001005382
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Whole genome sequencing (bam files) of 5 samples of myxofibrosarcoma and 5 matched pairs
Study
EGAS00001005444
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
Study
EGAS00001005437
-
Whole exome sequencing (bam files) of 55 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005442
-
Targeted-capture sequencing (bam files) of 81 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005443
-
TRACERx esophageal adenocarcinoma
Dac
EGAC00001000340
-
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Study
EGAS00001005478
-
IMCISION DNAseq
Study
EGAS00001005466
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Immune profiling reveals enrichment of distinct immune signatures in high-risk oral potentially malignant disorders
Study
EGAS00001005520
-
Dynamic N6-methyladenosine Epitranscriptomic Landscape in Lung Adenocarcinoma
Study
EGAS00001005524
-
Genomic characterization of retinoblastoma (targeted sequencing)
Study
EGAS00001005550
-
Whole-transcriptome sequencing of hepatocellular carcinoma biopsies (TACE study)
Study
EGAS00001005558
-
The genomic landscape of early stage ovarian high grade serous carcinoma
Study
EGAS00001005567
-
Berlin Neuroblastoma Dataset Update 2021
Study
EGAS00001005604
-
RNA-seq on neuroblastoma PDX model COG-N-519 treated with control miR-1283 and test miR-99b-5p mimics
Study
EGAS00001005581
-
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Study
EGAS00001005592
-
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
Study
EGAS00001005617
-
PIK3CA mutation in a case of CTNNB1 mutant sinonasal glomangiopericytoma
Study
EGAS00001005653
-
Pre-neoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
Study
EGAS00001005656
-
MM samples for epigenomic translocation of H3K4me3 broad domains following super-enhancer hijacking
Study
EGAS00001005684
-
Targeted sequencing data and shallow whole genome sequencing data of Follicular lymphoma.
Study
EGAS00001005755
-
Clinical impact of immune checkpoint inhibitor (ICI) response, DNA damage repair (DDR) gene mutations and immune-cell infiltration in subtypes of metastatic melanoma
Study
EGAS00001005781
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001005784
-
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
Study
EGAS00001005786
-
Study of pediatric hepatocellular carcinoma with BSEP deficiency
Dac
EGAC00001000191
-
Myeloma methylation
Study
EGAS00001005788
-
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Study
EGAS00001005791
-
RNA-seq data from 27 glioblastoma samples
Study
EGAS00001005807
-
Paired data of primary and relapse central nervous system lymphoma and testicular lymphoma
Study
EGAS00001005833
-
NLG-LBC-05 ctDNA
Study
EGAS00001005835
-
SPECTA RP-1759-AYA Sarcoma cohort
Study
EGAS00001005840
-
tFL with a PMBL GE signature
Study
EGAS00001005870
-
Patient-derived tumor organoids for personalized medicine in a rare case of hepatocellular carcinoma with neuroendocrine differentiation.
Study
EGAS00001005887
-
Origins and timing of emerging lesions in advanced renal cell carcinoma
Study
EGAS00001005897
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Genomic and transcriptome analysis for intrahepatic cholangiocarcinoma
Study
EGAS00001006007
-
Application of high-throughput, high-depth, targeted single-nucleus DNA sequencing in pancreatic cancer
Study
EGAS00001006024
-
Targeted analysis of cell-free circulating tumor DNA is suitable for early relapse and actionable target detection in patients with neuroblastoma
Study
EGAS00001006027
-
early-stage ESCC sequencing study
Study
EGAS00001006126
-
RP-1843 Arcagen - Gastrointestinal rare cancers (GI)
Study
EGAS00001006299
-
A multi-center genome-wide association study for nasopharyngeal carcinoma
Study
EGAS00001006062
-
Genomic and transcriptomic analysis of baseline PDAC patients' tumors from the OXIRI phase 1b clinical trial
Study
EGAS00001006073
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
USARC 10X Genomics Single Cell DNA Sequencing Data
Study
EGAS00001006144
-
Whole exome sequencing study of cholesteatoma patients from affected families
Study
EGAS00001006147
-
Genomic profiling of metastatic basal cell carcinoma reveals candidate drivers of disease and therapeutic targets
Study
EGAS00001006148
-
Molecular and clinical diversity in primary central nervous system lymphoma: a LOC Network study
Study
EGAS00001006191
-
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Study
EGAS00001006196
-
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Study
EGAS00001006200
-
MGP Panel: a comprehensive targeted genomics panel for molecular profiling of multiple myeloma patients
Study
EGAS00001006222
-
Salivary Gland Cancer TSO500 dataset
Study
EGAS00001006232
-
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Study
EGAS00001006293
-
Clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancers defined by genomic analysis
Study
EGAS00001006306
-
Long-read sequencing for cell-free DNA analysis (human)
Study
EGAS00001006328
-
Intratumoural heterogeneity and immune modulation in lung adenocarcinoma of female smokers and never smokers
Study
EGAS00001006331
-
Molecular determinants of outcomes in relapsed mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Study
EGAS00001006342
-
Placebo-only arm transcriptomic analysis of the phase 3 PROTECT clinical trial
Study
EGAS00001006344
-
Clonal dominance defines metastatic dissemination in pancreatic cancer
Study
EGAS00001006358
-
Whole exome-sequencing of pediatric and adult H3-K27M diffuse midline glioma
Study
EGAS00001006431
-
Glioma exome array DAC
Dac
EGAC00001000345
-
Whole genome landscape of 25 metastatic cutaneous squamous cell carcinoma cSCC patients
Study
EGAS00001006378
-
Quantitative Exploratory Proteomics Analysis of Glioblastoma in Initial and Recurrent Tumors
Study
EGAS00001006395
-
Molecular profiling of EBV associated diffuse large B-cell lymphoma
Study
EGAS00001006400
-
DNA methylation-based prognostic subtypes of chordoma tumors in tissue
Study
EGAS00001006406